Top

International Urology and Nephrology

Published in:

01-03-2019 | Nephrectomy | Urology - Review

Organ-sparing procedures in GU cancer: part 1—organ-sparing procedures in renal and adrenal tumors: a systematic review

Authors: Raouf Seyam, Mahmoud I. Khalil, Mohamed H. Kamel, Waleed M. Altaweel, Rodney Davis, Nabil K. Bissada

Published in: International Urology and Nephrology | Issue 3/2019

Abstract

Purpose

Organ-sparing surgery (OSS) for the kidney and adrenals has emerged as the need for preservation of function is paramount in patients with poor functional reserve. As reports increasingly showed that oncological outcomes were equivalent to radical excision, elective OSS became a viable alternative in patients with otherwise normal reserve. In this review, we summarize the current knowledge of OSS for adrenal and renal tumors.

Materials and methods

PubMed, Web of Science and Cochrane Library Central Search were searched for recently published articles up to December 2017. The following keywords were used; “partial adrenalectomy”, “adrenal sparing”, “partial nephrectomy”, “nephron sparing”, “kidney/renal cancer”.

Results

Partial adrenalectomy became an attractive alternative to total adrenalectomy avoiding adrenal insufficiency. Both minimally invasive surgery and ablative techniques were increasingly reported for adrenal OSS with adequate residual adrenal function and excellent oncological outcome. Radical nephrectomy remained for many years as the gold standard of treatment for organ-confined renal cell carcinoma. As the need to reduce the impact on renal function, more conservative approaches were utilized. Soon, the non-inferiority of nephron-sparing surgery to that of radical excision became evident and elective partial nephrectomy was gaining ground as the standard of care for small renal masses in patients with normal contralateral kidneys.

Conclusions

Herein, we present a comprehensive review of the current status of OSS in renal and adrenal tumors.

Telenius-Berg M, Ponder MA, Berg B, Ponder BA, Werner S (1989) Quality of life after bilateral adrenalectomy in MEN 2. Henry Ford Hosp Med J 37:160–163PubMed

Asari R, Scheuba C, Kaczirek K, Niederle B (2006) Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg 141:1199–1205. https://doi.org/10.1001/archsurg.141.12.1199 (discussion 1205)CrossRefPubMed

van Heerden JA, Sizemore GW, Carney JA, Grant CS, ReMine WH, Sheps SG (1984) Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 8:612–621PubMed

Sasagawa I, Suzuki Y, Itoh K, Izumi T, Miura M, Suzuki H, Tomita Y (2003) Posterior retroperitoneoscopic partial adrenalectomy: clinical experience in 47 procedures. Eur Urol 43:381–385PubMed

Iihara M, Suzuki R, Kawamata A, Omi Y, Kodama H, Igari Y, Yamazaki K, Obara T (2003) Adrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumors. Surgery 134:1066–1072. https://doi.org/10.1016/j.surg.2003.07.027 (discussion 1072–1073)CrossRefPubMed

Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120:1064–1070 (discussion 1070–1071)PubMed

Baghai M, Thompson GB, Young WFJ, Grant CS, Michels VV, van Heerden JA (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–688 (discussion 688–689)PubMed

Liao C-H, Chung S-D, Lai M-K, Yu H-J, Chueh S-C (2009) Laparoscopic simultaneous bilateral partial and total adrenalectomy: a longer follow-up. BJU Int 104:1269–1273. https://doi.org/10.1111/j.1464-410X.2009.08523.x CrossRefPubMed

Brauckhoff M, Gimm O, Thanh PN, Bar A, Ukkat J, Brauckhoff K, Bonsch T, Dralle H (2003) Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. Surgery 134:1020–1027. https://doi.org/10.1016/j.surg.2003.08.005 (discussion 1027–1028)CrossRefPubMed

10.

Brauckhoff M, Stock K, Stock S, Lorenz K, Sekulla C, Brauckhoff K, Thanh PN, Gimm O, Spielmann RP, Dralle H (2008) Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy. World J Surg 32:863–872. https://doi.org/10.1007/s00268-007-9402-y CrossRefPubMed

11.

Walz MK (2009) Adrenalectomy for preservation of adrenocortical function. Indication and results. Chir Z Alle Geb Oper Medizen 80:99–104. https://doi.org/10.1007/s00104-008-1612-9 CrossRef

12.

Angeli A, Osella G, Ali A, Terzolo M (1997) Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 47:279–283PubMed

13.

Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010) Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 184:18–25. https://doi.org/10.1016/j.juro.2010.03.052 CrossRefPubMedPubMedCentral

14.

Kok KYY, Yapp SKS (2002) Laparoscopic adrenal-sparing surgery for primary hyperaldosteronism due to aldosterone-producing adenoma. Surg Endosc 16:108–111. https://doi.org/10.1007/s00464-001-8127-5 CrossRefPubMed

15.

Walther MM, Keiser HR, Linehan WM (1999) Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 17:35–39PubMed

16.

Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659–664PubMed

17.

Roukounakis N, Dimas S, Kafetzis I, Bethanis S, Gatsulis N, Kostas H, Kyriakou V, Michas S (2007) Is preservation of the adrenal vein mandatory in laparoscopic adrenal-sparing surgery? J Soc Laparoendosc Surg 11:215–218

18.

Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV, Halpern EF, Mueller PR, Hahn PF, Boland GW (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578–585. https://doi.org/10.1148/radiol.2382041514 CrossRefPubMed

19.

Sangwaiya MJ, Boland GWL, Cronin CG, Blake MA, Halpern EF, Hahn PF (2010) Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT—10-minute delayed imaging protocol revisited in a large patient cohort. Radiology 256:504–510. https://doi.org/10.1148/radiol.10091386 CrossRefPubMed

20.

Dunnick NR, Heaston D, Halvorsen R, Moore AV, Korobkin M (1982) CT appearance of adrenal cortical carcinoma. J Comput Assist Tomogr 6:978–982PubMed

21.

Fishman EK, Deutch BM, Hartman DS, Goldman SM, Zerhouni EA, Siegelman SS (1987) Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 148:531–535. https://doi.org/10.2214/ajr.148.3.531 CrossRefPubMed

22.

Hedican SP, Marshall FF (1997) Adrenocortical carcinoma with intracaval extension. J Urol 158:2056–2061PubMed

23.

Imai T, Tanaka Y, Kikumori T, Ohiwa M, Matsuura N, Mase T, Funahashi H (1999) Laparoscopic partial adrenalectomy. Surg Endosc 13:343–345PubMed

24.

Gupta GN, Benson JS, Ross MJ, Sundaram VS, Lin KY, Pinto PA, Linehan WM, Bratslavsky G (2014) Perioperative, functional, and oncologic outcomes of partial adrenalectomy for multiple ipsilateral pheochromocytomas. J Endourol 28:112–116. https://doi.org/10.1089/end.2013.0298 CrossRefPubMedPubMedCentral

25.

Manny TB, Pompeo AS, Hemal AK (2013) Robotic partial adrenalectomy using indocyanine green dye with near-infrared imaging: the initial clinical experience. Urology 82:738–742. https://doi.org/10.1016/j.urology.2013.03.074 CrossRefPubMed

26.

Ethier MD, Beland MD, Mayo-Smith W (2013) Image-guided ablation of adrenal tumors. Tech Vasc Interv Radiol 16:262–268. https://doi.org/10.1053/j.tvir.2013.08.008 CrossRefPubMed

27.

Yang R, Xu L, Lian H, Gan W, Guo H (2014) Retroperitoneoscopic-guided cool-tip radiofrequency ablation of adrenocortical aldosteronoma. J Endourol 28:1208–1214. https://doi.org/10.1089/end.2013.0635 CrossRefPubMed

28.

Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB (2004) Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198:525–534. https://doi.org/10.1016/j.jamcollsurg.2003.12.001 (discussion 534–535)CrossRefPubMed

29.

Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T (2013) Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma? Urol Oncol 31:36–41. https://doi.org/10.1016/j.urolonc.2010.08.026 CrossRefPubMed

30.

Autorino R, Porpiglia F, Dasgupta P, Rassweiler J, Catto JW, Hampton LJ, Lima E, Mirone V, Derweesh IH, Debruyne FMJ (2017) Precision surgery and genitourinary cancers. Eur J Surg Oncol 43:893–908. https://doi.org/10.1016/j.ejso.2017.02.005 CrossRefPubMed

31.

Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Colombel M, Klotz L, Skinner E, Keane T, Marreaud S, Collette S, Sylvester R (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552. https://doi.org/10.1016/j.eururo.2010.12.013 CrossRefPubMed

32.

Small AC, Tsao C-K, Moshier EL, Gartrell BA, Wisnivesky JP, Godbold J, Sonpavde G, Palese MA, Hall SJ, Oh WK, Galsky MD (2013) Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World J Urol 31:1211–1217. https://doi.org/10.1007/s00345-012-0873-6 CrossRefPubMed

33.

Fernando A, Fowler S, O’Brien T (2016) Nephron-sparing surgery across a nation—outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit. BJU Int 117:874–882. https://doi.org/10.1111/bju.13353 CrossRefPubMed

34.

Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW (2006) Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol 175:2027–2031. https://doi.org/10.1016/S0022-5347(06)00271-0 CrossRefPubMed

35.

Zargar-Shoshtari K, Kim T, Simon R, Lin H-Y, Yue B, Sharma P, Spiess PE, Poch MA, Pow Sang J, Sexton WJ (2015) Surveillance following nephron-sparing surgery: an assessment of recurrence patterns and surveillance costs. Urology 86:321–326. https://doi.org/10.1016/j.urology.2015.05.013 CrossRefPubMed

36.

Lai TC, Ma WK, Yiu MK (2016) Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go. Hong Kong Med J 22:39–45. https://doi.org/10.12809/hkmj144482 CrossRefPubMed

37.

Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML (2009) Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 182:2601–2606. https://doi.org/10.1016/j.juro.2009.08.087 CrossRefPubMedPubMedCentral

38.

Milonas D, Skulcius G, Baltrimavicius R, Auskalnis S, Kincius M, Matjosaitis A, Gudinaviciene I, Smailyte G, Jievaltas M (2013) Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma. Medicina 49:223–228PubMed

39.

Meskawi M, Becker A, Bianchi M, Trinh Q-D, Roghmann F, Tian Z, Graefen M, Perrotte P, Karakiewicz PI, Sun M (2014) Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma. Int J Urol 21:122–128. https://doi.org/10.1111/iju.12204 CrossRefPubMed

40.

Weight CJ, Larson BT, Fergany AF, Gao T, Lane BR, Campbell SC, Kaouk JH, Klein EA, Novick AC (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323. https://doi.org/10.1016/j.juro.2009.12.030 CrossRefPubMed

41.

Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R (2017) Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol 71:606–617. https://doi.org/10.1016/j.eururo.2016.08.060 CrossRefPubMed

42.

Lopez-Costea MA, Bonet X, Perez-Reggeti J, Etcheverry B, Vigues F (2016) Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma. Int Urol Nephrol 48:681–686. https://doi.org/10.1007/s11255-016-1217-z CrossRefPubMed

43.

Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V, Eisen T, Horwich A (2014) Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii49–i56. https://doi.org/10.1093/annonc/mdu259 CrossRefPubMed

44.

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924. https://doi.org/10.1016/j.eururo.2015.01.005 CrossRefPubMed

45.

Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, Gill I, Graham D, Huang W, Jewett MAS, Latcha S, Lowrance W, Rosner M, Shayegan B, Thompson RH, Uzzo R, Russo P (2017) Management of small renal masses: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 35:668–680. https://doi.org/10.1200/JCO.2016.69.9645 CrossRefPubMed

46.

Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervais DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM (2017) Renal mass and localized renal cancer: AUA guideline. J Urol 198:520–529. https://doi.org/10.1016/j.juro.2017.04.100 CrossRefPubMed

47.

Cost NG, Sawicz-Birkowska K, Kajbafzadeh A-M, Tourchi A, Parigi GB, Guillen G, DeFoor WRJ, Apoznanski W (2014) A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor. Urology 83:1388–1393. https://doi.org/10.1016/j.urology.2014.01.051 CrossRefPubMed

48.

Wilde JCH, Aronson DC, Sznajder B, Van Tinteren H, Powis M, Okoye B, Cecchetto G, Audry G, Fuchs J, Schweinitz DV, Heij H, Graf N, Bergeron C, Pritchard-Jones K, Van Den Heuvel-Eibrink M, Carli M, Oldenburger F, Sandstedt B, De Kraker J, Godzinski J (2014) Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience. Pediatr Blood Cancer 61:2175–2179. https://doi.org/10.1002/pbc.25185 CrossRefPubMed

49.

Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JRJ, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46. https://doi.org/10.1016/j.juro.2007.03.038 CrossRefPubMed

50.

Marszalek M, Meixl H, Polajnar M, Rauchenwald M, Jeschke K, Madersbacher S (2009) Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol 55:1171–1178. https://doi.org/10.1016/j.eururo.2009.01.042 CrossRefPubMed

51.

Lane BR, Gill IS (2010) 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol 183:473–479. https://doi.org/10.1016/j.juro.2009.10.023 CrossRefPubMed

52.

Shikanov S, Lifshitz D, Chan AA, Okhunov Z, Ordonez MA, Wheat JC, Matin SF, Landman J, Wolf JSJ, Eggener SE, Shalhav AL (2010) Impact of ischemia on renal function after laparoscopic partial nephrectomy: a multicenter study. J Urol 183:1714–1718. https://doi.org/10.1016/j.juro.2010.01.007 CrossRefPubMed

53.

Adamy A, Favaretto RL, Nogueira L, Savage C, Russo P, Coleman J, Guillonneau B, Touijer K (2010) Recovery of renal function after open and laparoscopic partial nephrectomy. Eur Urol 58:596–601. https://doi.org/10.1016/j.eururo.2010.05.044 CrossRefPubMed

54.

Springer C, Hoda MR, Fajkovic H, Pini G, Mohammed N, Fornara P, Greco F (2013) Laparoscopic vs open partial nephrectomy for T1 renal tumours: evaluation of long-term oncological and functional outcomes in 340 patients. BJU Int 111:281–288. https://doi.org/10.1111/j.1464-410X.2012.11280.x CrossRefPubMed

55.

Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G (2013) Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol 27:196–201. https://doi.org/10.1089/end.2012.0483 CrossRefPubMedPubMedCentral

56.

Masson-Lecomte A, Bensalah K, Seringe E, Vaessen C, de la Taille A, Doumerc N, Rischmann P, Bruyere F, Soustelle L, Droupy S, Roupret M (2013) A prospective comparison of surgical and pathological outcomes obtained after robot-assisted or pure laparoscopic partial nephrectomy in moderate to complex renal tumours: results from a French multicentre collaborative study. BJU Int 111:256–263. https://doi.org/10.1111/j.1464-410X.2012.11528.x CrossRefPubMed

57.

Aboumarzouk OM, Stein RJ, Eyraud R, Haber G-P, Chlosta PL, Somani BK, Kaouk JH (2012) Robotic versus laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol 62:1023–1033. https://doi.org/10.1016/j.eururo.2012.06.038 CrossRefPubMed

58.

Hung AJ, Cai J, Simmons MN, Gill IS (2013) “Trifecta” in partial nephrectomy. J Urol 189:36–42. https://doi.org/10.1016/j.juro.2012.09.042 CrossRefPubMed

59.

Long J-A, Yakoubi R, Lee B, Guillotreau J, Autorino R, Laydner H, Eyraud R, Stein RJ, Kaouk JH, Haber G-P (2012) Robotic versus laparoscopic partial nephrectomy for complex tumors: comparison of perioperative outcomes. Eur Urol 61:1257–1262. https://doi.org/10.1016/j.eururo.2012.03.012 CrossRefPubMed

60.

Hankins RA, Walton-Diaz A, Truong H, Shih J, Bratslavsky G, Pinto PA, Linehan WM, Metwalli AR (2016) Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidney. Int Urol Nephrol 48:1817–1821. https://doi.org/10.1007/s11255-016-1392-y CrossRefPubMedPubMedCentral

61.

Ng CK, Gill IS, Patil MB, Hung AJ, Berger AK, de Castro Abreu AL, Nakamoto M, Eisenberg MS, Ukimura O, Thangathurai D, Aron M, Desai MM (2012) Anatomic renal artery branch microdissection to facilitate zero-ischemia partial nephrectomy. Eur Urol 61:67–74. https://doi.org/10.1016/j.eururo.2011.08.040 CrossRefPubMed

62.

Palacios DA, McDonald M, Miyake M, Rosser CJ (2013) Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy. BMC Res Notes. https://doi.org/10.1186/1756-0500-6-399 CrossRefPubMedPubMedCentral

63.

Greco F, Cadeddu JA, Gill IS, Kaouk JH, Remzi M, Thompson RH, van Leeuwen FWB, van der Poel HG, Fornara P, Rassweiler J (2014) Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers. Eur Urol 65:947–964. https://doi.org/10.1016/j.eururo.2013.07.033 CrossRefPubMed

64.

Minervini A, Serni S, Tuccio A, Siena G, Vittori G, Masieri L, Giancane S, Lanciotti M, Khorrami S, Lapini A, Carini M (2012) Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. Ann Surg Oncol 19:694–700. https://doi.org/10.1245/s10434-011-2003-x CrossRefPubMed

65.

Serni S, Vittori G, Frizzi J, Mari A, Siena G, Lapini A, Carini M, Minervini A (2015) Simple enucleation for the treatment of highly complex renal tumors: perioperative, functional and oncological results. Eur J Surg Oncol 41:934–940. https://doi.org/10.1016/j.ejso.2015.02.019 CrossRefPubMed

66.

Jewett MAS, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60:39–44. https://doi.org/10.1016/j.eururo.2011.03.030 CrossRefPubMed

67.

Zondervan PJ, Buijs M, De Bruin DM, van Delden OM, Van Lienden KP (2018) Available ablation energies to treat cT1 renal cell cancer: emerging technologies. World J Urol. https://doi.org/10.1007/s00345-018-2546-6 CrossRefPubMedPubMedCentral

68.

Prins FM, Kerkmeijer LGW, Pronk AA, Vonken E-JPA, Meijer RP, Bex A, Barendrecht MM (2017) Renal cell carcinoma: alternative nephron-sparing treatment options for small renal masses, a systematic review. J Endourol 31:963–975. https://doi.org/10.1089/end.2017.0382 CrossRefPubMed

69.

Xing M, Kokabi N, Zhang D, Ludwig JM, Kim HS (2018) Comparative effectiveness of thermal ablation, surgical resection, and active surveillance for T1a renal cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER)-medicare-linked population study. Radiology 288:81–90. https://doi.org/10.1148/radiol.2018171407 CrossRefPubMed

70.

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486–492. https://doi.org/10.1016/j.eururo.2012.08.062 CrossRefPubMed

71.

Thorstenson A, Bergman M, Scherman-Plogell A-H, Hosseinnia S, Ljungberg B, Adolfsson J, Lundstam S (2014) Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden. Scand J Urol 48:231–238. https://doi.org/10.3109/21681805.2013.864698 CrossRefPubMed

72.

Krokidis ME, Kitrou P, Spiliopoulos S, Karnabatidis D, Katsanos K (2018) Image-guided minimally invasive treatment for small renal cell carcinoma. Insights Imaging 9:385–390. https://doi.org/10.1007/s13244-018-0607-4 CrossRefPubMedPubMedCentral

73.

Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S (2016) Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol 34:1081–1086. https://doi.org/10.1007/s00345-016-1773-y CrossRefPubMed

74.

Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P, Marconi L, Fernandez-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staehler M, Ljungberg B, Bex A (2018) Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.02.010 CrossRefPubMed

75.

Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR (2011) Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77:1393–1397. https://doi.org/10.1016/j.urology.2010.12.077 CrossRefPubMed

76.

Ma Y, Bedir S, Cadeddu JA, Gahan JC (2014) Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int 113:51–55. https://doi.org/10.1111/bju.12366 CrossRefPubMed

77.

Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ (2014) Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 113:416–428. https://doi.org/10.1111/bju.12349 CrossRefPubMed

78.

Su MZ, Memon F, Lau HM, Brooks AJ, Patel MI, Woo HH, Bariol SV, Vladica P (2016) Safety, efficacy and predictors of local recurrence after percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma. Int Urol Nephrol 48:1609–1616. https://doi.org/10.1007/s11255-016-1355-3 CrossRefPubMed

79.

Zhang F, Chang X, Liu T, Wang W, Zhao X, Ji C, Yang R, Guo H (2016) Prognostic factors for long-term survival in patients with renal-cell carcinoma after radiofrequency ablation. J Endourol 30:37–42. https://doi.org/10.1089/end.2015.0454 CrossRefPubMed

80.

Johnson B, Sorokin I, Cadeddu JA (2018) Ten-year outcomes of renal tumor radiofrequency ablation. J Urol. https://doi.org/10.1016/j.juro.2018.08.045 CrossRefPubMed

81.

Talenfeld AD, Gennarelli RL, Elkin EB, Atoria CL, Durack JC, Huang WC, Kwan SW (2018) Percutaneous ablation versus partial and radical nephrectomy for T1a renal cancer: a population-based analysis. Ann Intern Med 169:69–77. https://doi.org/10.7326/M17-0585 CrossRefPubMed

82.

Zhou M, Mills A, Noda C, Ramaswamy R, Akinwande O (2018) SEER study of ablation versus partial nephrectomy in cT1A renal cell carcinoma. Future Oncol 14:1711–1719. https://doi.org/10.2217/fon-2017-0678 CrossRefPubMed

83.

Sung HH, Park BK, Kim CK, Choi HY, Lee HM (2012) Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses. Int J Hyperth 28:227–234. https://doi.org/10.3109/02656736.2012.666319 CrossRef

84.

Cooper CJ, Teleb M, Dwivedi A, Rangel G, Sanchez LA, Laks S, Akle N, Nahleh Z (2015) Comparative outcome of computed tomography-guided percutaneous radiofrequency ablation, partial nephrectomy or radical nephrectomy in the treatment of stage T1 renal cell carcinoma. Rare Tumors. https://doi.org/10.4081/rt.2015.5583 CrossRefPubMedPubMedCentral

85.

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61:1156–1161. https://doi.org/10.1016/j.eururo.2012.01.001 CrossRefPubMed

86.

Takaki H, Soga N, Kanda H, Nakatsuka A, Uraki J, Fujimori M, Yamanaka T, Hasegawa T, Arima K, Sugimura Y, Sakuma H, Yamakado K (2014) Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology 270:292–299. https://doi.org/10.1148/radiol.13130221 CrossRefPubMed

87.

Liu N, Huang D, Cheng X, Chong Y, Wang W, Gan W, Guo H (2017) Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype. Urol Oncol 35:530.e1–530.e6. https://doi.org/10.1016/j.urolonc.2017.03.014 CrossRef

88.

Park BK, Gong IH, Kang MY, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Seo SI (2018) RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome. Eur Radiol 28:2979–2985. https://doi.org/10.1007/s00330-018-5305-6 CrossRefPubMed

89.

Zhou W, Uppot RN, Feldman AS, Arellano RS (2017) Percutaneous image-guided thermal ablation for multifocal renal cell carcinoma. AJR Am J Roentgenol 209:733–739. https://doi.org/10.2214/AJR.17.18290 CrossRefPubMed

90.

Camacho JC, Kokabi N, Xing M, Master VA, Pattaras JG, Mittal PK, Kim HS (2015) RENAL (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience. J Vasc Interv Radiol 26:686–693. https://doi.org/10.1016/j.jvir.2015.01.008 CrossRefPubMed

91.

Seklehner S, Fellner H, Engelhardt PF, Schabauer C, Riedl C (2013) Percutaneous radiofrequency ablation of renal tumors: a single-center experience. Korean J Urol 54:580–586. https://doi.org/10.4111/kju.2013.54.9.580 CrossRefPubMedPubMedCentral

92.

Takaki H, Nakatsuka A, Uraki J, Yamanaka T, Fujimori M, Hasegawa T, Arima K, Sugimura Y, Yamakado K (2013) Renal cell carcinoma: radiofrequency ablation with a multiple-electrode switching system—a phase II clinical study. Radiology 267:285–292. https://doi.org/10.1148/radiol.12121070 CrossRefPubMed

93.

Pantelidou M, Challacombe B, McGrath A, Brown M, Ilyas S, Katsanos K, Adam A (2016) Percutaneous radiofrequency ablation versus robotic-assisted partial nephrectomy for the treatment of small renal cell carcinoma. Cardiovasc Interv Radiol 39:1595–1603. https://doi.org/10.1007/s00270-016-1417-z CrossRef

94.

Davol PE, Fulmer BR, Rukstalis DB (2006) Long-term results of cryoablation for renal cancer and complex renal masses. Urology 68:2–6. https://doi.org/10.1016/j.urology.2006.03.066 CrossRefPubMed

95.

Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O’Malley C, Remer EM, Kaouk JH (2015) Laparoscopic cryoablation for renal cell carcinoma: 100-month oncologic outcomes. J Urol 194(4):892–896. https://doi.org/10.1016/j.juro.2015.03.128 CrossRefPubMed

96.

Nielsen TK, Lagerveld BW, Keeley F, Lughezzani G, Sriprasad S, Barber NJ, Hansen LU, Buffi NM, Guazzoni G, van der Zee JA, Ismail M, Farrag K, Emara AM, Lund L, Ostraat O, Borre M (2017) Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study. BJU Int 119:390–395. https://doi.org/10.1111/bju.13615 CrossRefPubMed

97.

Breen DJ, King AJ, Patel N, Lockyer R, Hayes M (2018) Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289:554–561. https://doi.org/10.1148/radiol.2018180249 CrossRefPubMed

98.

Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD (2018) Percutaneous cryoablation of solitary, sporadic renal cell carcinoma: outcome analysis based on clear-cell versus papillary subtypes. J Vasc Interv Radiol 29:1122–1126. https://doi.org/10.1016/j.jvir.2018.02.029 CrossRefPubMed

99.

Pessoa RR, Autorino R, Laguna MP, Molina WR, Gustafson D, Nogueira L, da Silva RD, Werahera PN, Kim FJ (2017) Laparoscopic versus percutaneous cryoablation of small renal mass: systematic review and cumulative analysis of comparative studies. Clin Genitourin Cancer 15:513–519. https://doi.org/10.1016/j.clgc.2017.02.003 CrossRefPubMed

100.

Zargar H, Samarasekera D, Khalifeh A, Remer EM, O’Malley C, Akca O, Autorino R, Kaouk JH (2015) Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology 85:850–855. https://doi.org/10.1016/j.urology.2015.01.004 CrossRefPubMed

101.

Faba OR, Sanguedolce F, Grange P, Kooiman G, Bakavicius A, De la Torre P, Palou J (2016) Kidney cancer focal cryoablation trend: does location or approach matter? World J Urol 34:917–923. https://doi.org/10.1007/s00345-015-1716-z CrossRef

102.

Caputo PA, Zargar H, Ramirez D, Andrade HS, Akca O, Gao T, Kaouk JH (2017) Cryoablation versus partial nephrectomy for clinical T1b renal tumors: a matched group comparative analysis. Eur Urol 71:111–117. https://doi.org/10.1016/j.eururo.2016.08.039 CrossRefPubMed

103.

Hasegawa T, Yamanaka T, Gobara H, Miyazaki M, Takaki H, Sato Y, Inaba Y, Yamakado K (2018) Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Jpn J Radiol 36:551–558. https://doi.org/10.1007/s11604-018-0756-x CrossRefPubMed

104.

Zhou W, Arellano RS (2018) Thermal ablation of T1c renal cell carcinoma: a comparative assessment of technical performance, procedural outcome, and safety of microwave ablation, radiofrequency ablation, and cryoablation. J Vasc Interv Radiol 29:943–951. https://doi.org/10.1016/j.jvir.2017.12.020 CrossRefPubMed

105.

Guan W, Bai J, Liu J, Wang S, Zhuang Q, Ye Z, Hu Z (2012) Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol 106:316–321. https://doi.org/10.1002/jso.23071 CrossRefPubMed

106.

Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh B, Correa RJ, Lo SS, Staehler M (2018) Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer 124:934–942. https://doi.org/10.1002/cncr.31156 CrossRefPubMed

107.

Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, Antonio EC, Noyes SL, Zaid H, Jaimes EA, Russo P (2017) Long-term renal functional recovery following radical nephrectomy for kidney cancer: results from a multi-center confirmatory study. J Urol. https://doi.org/10.1016/j.juro.2017.10.027 CrossRefPubMedPubMedCentral

108.

Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P (2016) Factors associated with recovery of renal function following radical nephrectomy for kidney neoplasms. Clin J Am Soc Nephrol 11:101–107. https://doi.org/10.2215/CJN.04070415 CrossRefPubMed

109.

Kawamura N, Yokoyama M, Fujii Y, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K (2016) Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter longitudinal study. Int J Urol 23:219–223. https://doi.org/10.1111/iju.13028 CrossRefPubMed

110.

Berczi C, Thomas B, Bacso Z, Flasko T (2016) Long-term oncological and functional outcomes of partial nephrectomy in solitary kidneys. Clin Genitourin Cancer 14:e275–e281. https://doi.org/10.1016/j.clgc.2015.11.014 CrossRefPubMed

111.

Costabel JI, Marchinena PG, Tirapegui F, Dantur A, Jurado A, Gueglio G (2016) Functional and oncologic outcomes after nephron-sparing surgery in a solitary kidney: 10 years of experience. Int Braz J Urol 42:253–261PubMedPubMedCentral

112.

Pahernik S, Roos F, Wiesner C, Thuroff JW (2007) Nephron sparing surgery for renal cell carcinoma in a solitary kidney. World J Urol 25:513–517. https://doi.org/10.1007/s00345-007-0207-2 CrossRefPubMed

113.

Ghoneim TP, Sjoberg DD, Lowrance W, Shariat SF, Savage C, Bernstein M, Russo P (2015) Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics. World J Urol 33:2023–2029. https://doi.org/10.1007/s00345-015-1581-9 CrossRefPubMedPubMedCentral

114.

Zargar H, Akca O, Autorino R, Brandao LF, Laydner H, Krishnan J, Samarasekera D, Stein RJ, Kaouk JH (2015) Ipsilateral renal function preservation after robot-assisted partial nephrectomy (RAPN): an objective analysis using mercapto-acetyltriglycine (MAG3) renal scan data and volumetric assessment. BJU Int 115:787–795. https://doi.org/10.1111/bju.12825 CrossRefPubMed

115.

Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong Y-N, Uzzo RG (2012) Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 188:2077–2083. https://doi.org/10.1016/j.juro.2012.07.100 CrossRefPubMedPubMedCentral

116.

Sun M, Trinh Q-D, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI (2012) A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol 61:725–731. https://doi.org/10.1016/j.eururo.2011.11.047 CrossRefPubMed

117.

Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H (2014) Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 65:372–377. https://doi.org/10.1016/j.eururo.2013.06.044 CrossRefPubMed

118.

Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ (2009) Long-term consequences of kidney donation. N Engl J Med 360:459–469. https://doi.org/10.1056/NEJMoa0804883 CrossRefPubMedPubMedCentral

119.

Danzig MR, Ghandour RA, Chang P, Wagner AA, Pierorazio PM, Allaf ME, McKiernan JM (2015) Active surveillance is superior to radical nephrectomy and equivalent to partial nephrectomy for preserving renal function in patients with small renal masses: results from the DISSRM registry. J Urol 194:903–909. https://doi.org/10.1016/j.juro.2015.03.093 CrossRefPubMed

120.

Lane BR, Fergany AF, Weight CJ, Campbell SC (2010) Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol 184:1286–1290. https://doi.org/10.1016/j.juro.2010.06.011 CrossRefPubMed

121.

Mason R, Kapoor A, Liu Z, Saarela O, Tanguay S, Jewett M, Finelli A, Lacombe L, Kawakami J, Moore R, Morash C, Black P, Rendon RA (2016) The natural history of renal function after surgical management of renal cell carcinoma: results from the Canadian Kidney Cancer Information System. Urol Oncol. https://doi.org/10.1016/j.urolonc.2016.05.025 CrossRefPubMed

122.

Roos FC, Brenner W, Thomas C, Jager W, Thuroff JW, Hampel C, Jones J (2012) Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 79:607–613. https://doi.org/10.1016/j.urology.2011.10.073 CrossRefPubMed

123.

Satasivam P, Reeves F, Rao K, Ivey Z, Basto M, Yip M, Roth H, Grummet J, Goad J, Moon D, Murphy D, Appu S, Lawrentschuk N, Bolton D, Kearsley J, Costello A, Frydenberg M (2015) Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery. BJU Int 116:590–595. https://doi.org/10.1111/bju.13075 CrossRefPubMed

124.

Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P (2006) Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol 176:472–476. https://doi.org/10.1016/j.juro.2006.03.090 (discussion 476)CrossRefPubMed

125.

Barlow LJ, Korets R, Laudano M, Benson M, McKiernan J (2010) Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis. BJU Int 106:489–492. https://doi.org/10.1111/j.1464-410X.2009.09147.x CrossRefPubMed

126.

Capitanio U, Terrone C, Antonelli A, Minervini A, Volpe A, Furlan M, Matloob R, Regis F, Fiori C, Porpiglia F, Di Trapani E, Zacchero M, Serni S, Salonia A, Carini M, Simeone C, Montorsi F, Bertini R (2015) Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol 67:683–689. https://doi.org/10.1016/j.eururo.2014.09.027 CrossRefPubMed

127.

Ljungberg B, Hedin O, Lundstam S, Warnolf A, Forsberg AM, Hjelle KM, Stief CG, Borlinghaus C, Beisland C, Staehler M (2016) Nephron sparing surgery associated with better survival than radical nephrectomy in patients treated for unforeseen benign renal tumors. Urology 93:117–123. https://doi.org/10.1016/j.urology.2016.01.037 CrossRefPubMed

128.

Jang HA, Kim JW, Byun SS, Hong SH, Kim YJ, Park YH, Yang KS, Cho S, Cheon J, Kang SH (2016) oncologic and functional outcomes after partial nephrectomy versus radical nephrectomy in T1b renal cell carcinoma: a multicenter, matched case-control study in Korean patients. Cancer Res Treat 48:612–620. https://doi.org/10.4143/crt.2014.122 CrossRefPubMed

129.

Godoy G, Ramanathan V, Kanofsky JA, O’Malley RL, Tareen BU, Taneja SS, Stifelman MD (2009) Effect of warm ischemia time during laparoscopic partial nephrectomy on early postoperative glomerular filtration rate. J Urol 181:2438–2443. https://doi.org/10.1016/j.juro.2009.02.026 (discussion 2443–2445)CrossRefPubMed

130.

Zargar H, Akca O, Ramirez D, Brandao LF, Laydner H, Krishnan J, Stein RJ, Kaouk JH (2015) The impact of extended warm ischemia time on late renal function after robotic partial nephrectomy. J Endourol 29:444–448. https://doi.org/10.1089/end.2014.0557 CrossRefPubMed

131.

Mir MC, Takagi T, Campbell RA, Sharma N, Remer EM, Li J, Demirjian S, Stein R, Kaouk J, Campbell SC (2014) Poorly functioning kidneys recover from ischemia after partial nephrectomy as well as strongly functioning kidneys. J Urol 192:665–670. https://doi.org/10.1016/j.juro.2014.03.036 CrossRefPubMed

132.

Volpe A, Blute ML, Ficarra V, Gill IS, Kutikov A, Porpiglia F, Rogers C, Touijer KA, Van Poppel H, Thompson RH (2015) Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 68:61–74. https://doi.org/10.1016/j.eururo.2015.01.025 CrossRefPubMed

133.

Wang H-K, Qin X-J, Ma C-G, Shi G-H, Zhang H-L, Ye D-W (2016) Nephrometry score-guided off-clamp laparoscopic partial nephrectomy: patient selection and short-time functional results. World J Surg Oncol. https://doi.org/10.1186/s12957-016-0914-5 CrossRefPubMedPubMedCentral

134.

Shah PH, George AK, Moreira DM, Alom M, Okhunov Z, Salami S, Waingankar N, Schwartz MJ, Vira MA, Richstone L, Kavoussi LR (2016) To clamp or not to clamp? Long-term functional outcomes for elective off-clamp laparoscopic partial nephrectomy. BJU Int 117:293–299. https://doi.org/10.1111/bju.13309 CrossRefPubMed

135.

Kim JH, Park YH, Kim YJ, Kang SH, Byun SS, Kwak C, Hong SH (2015) Perioperative and long-term renal functional outcomes of robotic versus laparoscopic partial nephrectomy: a multicenter matched-pair comparison. World J Urol 33:1579–1584. https://doi.org/10.1007/s00345-015-1488-5 CrossRefPubMed

136.

Lee SH, Kim DS, Cho S, Kim SJ, Kang SH, Park J, Park SY, Chang S-G, Jeon SH (2015) Comparison of postoperative estimated glomerular filtration rate between kidney donors and radical nephrectomy patients, and risk factors for postoperative chronic kidney disease. Int J Urol 22:674–678. https://doi.org/10.1111/iju.12784 CrossRefPubMed

137.

Kim SH, Lee SE, Hong SK, Jeong CW, Park YH, Kim Y-J, Kang SH, Hong S-H, Choi WS, Byun S-S (2013) Incidence and risk factors of chronic kidney disease in korean patients with t1a renal cell carcinoma before and after radical or partial nephrectomy. Jpn J Clin Oncol 43:1243–1248. https://doi.org/10.1093/jjco/hyt149 CrossRefPubMed

138.

Kopp RP, Liss MA, Mehrazin R, Wang S, Lee HJ, Jabaji R, Mirheydar HS, Gillis K, Patel N, Palazzi KL, Wan JY, Patterson AL, Derweesh IH (2015) Analysis of renal functional outcomes after radical or partial nephrectomy for renal masses ≥ 7 cm using the RENAL score. Urology 86:312–319. https://doi.org/10.1016/j.urology.2015.02.067 CrossRefPubMed

139.

Zhao J, Zhang Z, Dong W, Remer EM, Li J, Ericson K, Patel T, Almassi N, Hinck B, Zabell J, Tourojman M, Lane BR, Campbell SC (2016) Preoperative prediction and postoperative surgeon assessment of volume preservation associated with partial nephrectomy: comparison with measured volume preservation. Urology 93:124–129. https://doi.org/10.1016/j.urology.2016.02.055 CrossRefPubMed

140.

Tanaka K, Furukawa J, Shigemura K, Hinata N, Ishimura T, Muramaki M, Miyake H, Fujisawa M (2015) Surgery-related outcomes and postoperative split renal function by scintigraphy evaluation in robot-assisted partial nephrectomy in complex renal tumors: an initial case series. J Endourol 29:29–34. https://doi.org/10.1089/end.2014.0042 CrossRefPubMed

141.

Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC (2011) Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 185:421–427. https://doi.org/10.1016/j.juro.2010.09.131 CrossRefPubMed

142.

Simmons MN, Fergany AF, Campbell SC (2011) Effect of parenchymal volume preservation on kidney function after partial nephrectomy. J Urol 186:405–410. https://doi.org/10.1016/j.juro.2011.03.154 CrossRefPubMed

143.

Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC (2012) Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury. J Urol 187:1667–1673. https://doi.org/10.1016/j.juro.2011.12.068 CrossRefPubMed

144.

Ginzburg S, Uzzo R, Walton J, Miller C, Kurz D, Li T, Handorf E, Gor R, Corcoran A, Viterbo R, Chen DYT, Greenberg RE, Smaldone MC, Kutikov A (2015) Residual parenchymal volume, not warm ischemia time, predicts ultimate renal functional outcomes in patients undergoing partial nephrectomy. Urology 86:300–305. https://doi.org/10.1016/j.urology.2015.04.043 CrossRefPubMed

145.

Isharwal S, Ye W, Wang A, Abraham J, Zabell J, Dong W, Wu J, Suk-Ouichai C, Caraballo ER, Gao T, Campbell SC (2018) Impact of comorbidities on functional recovery from partial nephrectomy. J Urol 199:1433–1439. https://doi.org/10.1016/j.juro.2017.12.004 CrossRefPubMed

146.

Zhu L, Wu G, Huang J, Wang J, Zhang R, Kong W, Xue W, Huang Y, Chen Y, Zhang J (2017) Comparing renal function preservation after laparoscopic radio frequency ablation assisted tumor enucleation and laparoscopic partial nephrectomy for clinical T1a renal tumor: using a 3D parenchyma measurement system. J Cancer Res Clin Oncol 143:905–912. https://doi.org/10.1007/s00432-017-2342-5 CrossRefPubMed

147.

Blackwell RH, Li B, Kozel Z, Zhang Z, Zhao J, Dong W, Capodice SE, Barton G, Shah A, Wetterlin JJ, Quek ML, Campbell SC, Gupta GN (2017) Functional implications of renal tumor enucleation relative to standard partial nephrectomy. Urology 99:162–168. https://doi.org/10.1016/j.urology.2016.07.048 CrossRefPubMed

148.

Mibu H, Tanaka N, Hosokawa Y, Kumamoto H, Margami N, Hirao Y, Fujimoto K (2015) Estimated functional renal parenchymal volume predicts the split renal function following renal surgery. World J Urol 33:1571–1577. https://doi.org/10.1007/s00345-014-1470-7 CrossRefPubMed

149.

Liss MA, DeConde R, Caovan D, Hofler J, Gabe M, Palazzi KL, Patel ND, Lee HJ, Ideker T, Van Poppel H, Karow D, Aertsen M, Casola G, Derweesh IH (2016) Parenchymal volumetric assessment as a predictive tool to determine renal function benefit of nephron-sparing surgery compared with radical nephrectomy. J Endourol 30:114–121. https://doi.org/10.1089/end.2015.0411 CrossRefPubMedPubMedCentral

150.

Tanaka H, Wang Y, Suk-Ouichai C, Palacios DA, Caraballo ER, Ye Y, Remer EM, Li J, Abouassaly R, Campbell SC (2018) Can we predict functional outcomes after partial nephrectomy? J Urol. https://doi.org/10.1016/j.juro.2018.09.055 CrossRefPubMed

151.

Kuru TH, Zhu J, Popeneciu IV, Rudhardt NS, Hadaschik BA, Teber D, Roethke M, Hohenfellner M, Zeier M, Pahernik SA (2014) Volumetry may predict early renal function after nephron sparing surgery in solitary kidney patients. SpringerPlus. https://doi.org/10.1186/2193-1801-3-488 CrossRefPubMedPubMedCentral

152.

Dagenais J, Maurice MJ, Mouracade P, Kara O, Malkoc E, Kaouk JH (2017) Excisional precision matters: understanding the influence of excisional volume loss on renal function after partial nephrectomy. Eur Urol 72:168–170. https://doi.org/10.1016/j.eururo.2017.02.004 CrossRefPubMed

153.

Dong W, Zhang Z, Zhao J, Wu J, Suk-Ouichai C, Aguilar Palacios D, Caraballo Antonio E, Babbar S, Remer EM, Li J, Isharwal S, Zabell J, Campbell SC (2017) Excised parenchymal mass during partial nephrectomy: functional implications. Urology 103:129–135. https://doi.org/10.1016/j.urology.2016.12.021 CrossRefPubMed

154.

Maurice MJ, Ramirez D, Malkoc E, Kara O, Nelson RJ, Caputo PA, Kaouk JH (2016) Predictors of excisional volume loss in partial nephrectomy: is there still room for improvement? Eur Urol 70:413–415. https://doi.org/10.1016/j.eururo.2016.05.007 CrossRefPubMed

155.

Bahler CD, Cary KC, Garg S, DeRoo EM, Tabib CH, Kansal JK, Monn MF, Flack CK, Masterson TA, Sandrasegaran MK, Foster RS, Sundaram CP (2015) Differentiating reconstructive techniques in partial nephrectomy: a propensity score analysis. Can J Urol 22:7788–7796PubMed

156.

Huang W-H, Chang C-H, Huang C-P, Wu H-C, Hsieh I P-F (2017) The percentage of resected and ischemic volume determined by a geometric model is a significant predictor of renal functional change after partial nephrectomy. Int Braz J Urol 43:80–86. https://doi.org/10.1590/S1677-5538.IBJU.2015.0423 CrossRefPubMedPubMedCentral

157.

Masago T, Yamaguchi N, Iwamoto H, Morizane S, Hikita K, Honda M, Sejima T, Takenaka A (2018) The significance of predictable traumatic area by renorrhaphy in the prediction of postoperative ipsilateral renal function. Cent Eur J Urol 71:64–71. https://doi.org/10.5173/ceju.2018.1557 CrossRef

158.

Rha KH, Abdel Raheem A, Park SY, Kim KH, Kim HJ, Koo KC, Choi YD, Jung BH, Lee SK, Lee WK, Krishnan J, Shin TY, Cho J-S (2017) Impact of preoperative calculation of nephron volume loss on future of partial nephrectomy techniques; planning a strategic roadmap for improving functional preservation and securing oncological safety. BJU Int 120:682–688. https://doi.org/10.1111/bju.13937 CrossRefPubMed

159.

Erdem S, Boyuk A, Tefik T, Yucel B, Naghiyev R, Ozsoy M, Verep S, Sanli O (2015) Warm ischemia-related postoperative renal dysfunction in elective laparoscopic partial nephrectomy recovers during intermediate-term follow-up. J Endourol 29:1083–1090. https://doi.org/10.1089/end.2015.0146 CrossRefPubMed

160.

Jeon HG, Gong IH, Hwang JH, Choi DK, Lee SR, Park DS (2012) Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy. BJU Int 109:1468–1473. https://doi.org/10.1111/j.1464-410X.2011.10531.x CrossRefPubMed

161.

Yossepowitch O, Eggener SE, Serio A, Huang WC, Snyder ME, Vickers AJ, Russo P (2006) Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function. J Urol 176:1339–1343. https://doi.org/10.1016/j.juro.2006.06.046 (discussion 1343)CrossRefPubMed

162.

Lane BR, Babineau DC, Poggio ED, Weight CJ, Larson BT, Gill IS, Novick AC (2008) Factors predicting renal functional outcome after partial nephrectomy. J Urol 180:2363–2368. https://doi.org/10.1016/j.juro.2008.08.036 (discussion 2368–2369)CrossRefPubMed

163.

Chung JS, Son NH, Byun S-S, Lee SE, Hong SK, Jeong CW, Lee SC, Chae D-W, Choi WS, Park YH, Hong SH, Kim YJ, Kang SH (2014) Trends in renal function after radical nephrectomy: a multicentre analysis. BJU Int 113:408–415. https://doi.org/10.1111/bju.12277 CrossRefPubMed

164.

Bazzi WM, Chen LY, Cordon BH, Mashni J, Sjoberg DD, Bernstein M, Russo P (2015) Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function. Int Urol Nephrol 47:1499–1502. https://doi.org/10.1007/s11255-015-1066-1 CrossRefPubMedPubMedCentral

165.

Filson CP, Schwartz K, Colt JS, Ruterbusch J, Linehan WM, Chow W-H, Miller DC (2014) Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension. Urol Oncol 32:27.e15–27.e21. https://doi.org/10.1016/j.urolonc.2012.09.014 CrossRef

Title: Organ-sparing procedures in GU cancer: part 1—organ-sparing procedures in renal and adrenal tumors: a systematic review
Authors: Raouf Seyam
Mahmoud I. Khalil
Mohamed H. Kamel
Waleed M. Altaweel
Rodney Davis
Nabil K. Bissada
Publication date: 01-03-2019
Publisher: Springer Netherlands
Keywords: Nephrectomy
Kidney Cancer
Adrenal Cancer
Kidney Cancer
Renal Cancer
Nephrectomy
Adrenalectomy
Adrenal Cancer
Kidney Cancer
Nephrectomy
Adrenalectomy
Published in: International Urology and Nephrology / Issue 3/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-018-02070-5

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Organ-sparing procedures in GU cancer: part 1—organ-sparing procedures in renal and adrenal tumors: a systematic review

Abstract

Purpose

Materials and methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2019

Usefulness of frailty evaluation for handling chronic kidney disease elderly patients: a review and original proposal

Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis

SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy

Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non-obstructive azoospermia?

Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism

Vaginoplasty and creating labia minora in children with disorders of sex development

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page